Identification of Subclinical Microvascular Biomarkers in Coronary Heart Disease in Retinal Imaging.
Journal
Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919
Informations de publication
Date de publication:
01 11 2021
01 11 2021
Historique:
entrez:
17
11
2021
pubmed:
18
11
2021
medline:
27
1
2022
Statut:
ppublish
Résumé
Cardiovascular disease and foremost coronary heart disease (CHD) are the worldwide leading causes of death. The aim of this study was to use non-invasive, multimodel retinal imaging to define microvascular features in patients with and without coronary angiography (CA)-confirmed CHD. In this prospective, cross-sectional pilot study we included adult patients who presented to a tertiary referral center for elective CA due to suspected CHD. All patients underwent widefield fundus photography for retinopathy grading. Optical coherence tomography angiography was used to measure vessel density (VD) of the individual capillary plexuses in 6 × 6-mm macular volume scans. Adaptive optics imaging was performed to assess the first-order arteriolar lumen diameter (LD), total diameter (TD), wall-to-lumen ratio (WLR), and wall cross-section area, as well as to qualitatively describe vessel morphology. Of the included 45 patients (13 females; 65 ± 10 years old), 27 were confirmed with CHD in elective CA. The most prevalent retinal vascular pathologies were arteriovenous nickings, focal arterial narrowings, and microaneurysms. VD in the superficial capillary plexus, deep capillary plexus, and choriocapillaris was lower in CHD patients, although the odds ratios were not significantly different from 1 (P = 0.06-0.92). Median arterial LD, TD, and WLR values were 98.3 µm (interquartile range [IQR] = 13.0), 122.9 µm (IQR = 17.6), and 0.26 µm (IQR = 0.07), respectively, with a trend toward a higher WLR in CHD patients. In a cardiovascular risk population, high-resolution quantitative and qualitative microvascular phenotyping in the retina may provide valuable subclinical indicators for coronary artery impairment, although larger clinical trials are needed. Subclinical retinal microvascular changes may serve as non-invasive, cost-effective biomarkers for risk stratification of patients with CHD.
Identifiants
pubmed: 34787666
pii: 2778089
doi: 10.1167/tvst.10.13.24
pmc: PMC8606892
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
24Références
JAMA Ophthalmol. 2016 Apr;134(4):367-73
pubmed: 26795548
Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1217-28
pubmed: 10752963
Retina. 2020 Oct;40(10):1964-1971
pubmed: 31800461
Sci Rep. 2019 May 30;9(1):8060
pubmed: 31147610
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4299-4306
pubmed: 30372758
BMJ. 2016 May 16;353:i2416
pubmed: 27184143
Ophthalmology. 2013 Dec;120(12):2587-2595
pubmed: 23778092
PLoS One. 2019 May 15;14(5):e0213653
pubmed: 31091238
Hypertension. 1993 Apr;21(4):391-7
pubmed: 8458640
Hypertension. 2007 Oct;50(4):617-22
pubmed: 17698721
JAMA. 2002 Mar 6;287(9):1153-9
pubmed: 11879113
J Am Coll Cardiol. 2007 Jul 3;50(1):48-55
pubmed: 17601545
Atherosclerosis. 2016 Sep;252:207-274
pubmed: 27664503
Am J Cardiol. 2008 Jul 1;102(1):58-63
pubmed: 18572036
Biomed Opt Express. 2019 Mar 04;10(4):1532-1544
pubmed: 31061756
J Hypertens. 2014 Apr;32(4):890-8
pubmed: 24406779
J Hypertens. 2016 Jun;34(6):1115-22
pubmed: 27065002
Eur Heart J. 2007 Aug;28(16):1984-92
pubmed: 17626032
J Ultrastruct Res. 1963 Aug;49:29-46
pubmed: 14058442
Dtsch Arztebl Int. 2017 Oct 20;114(42):712-719
pubmed: 29122104
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1691-8
pubmed: 19907024
Eye (Lond). 2005 Mar;19(3):322-6
pubmed: 15258601
Retina. 2013 Sep;33(8):1630-9
pubmed: 23492950
J Hypertens. 2014 Feb;32(2):207-15
pubmed: 24322199
Am J Cardiol. 2005 Oct 15;96(8):1107-9
pubmed: 16214446